Literature DB >> 6112701

Role of intracellular proteins in the regulation of calcium action and transmitter release during exocytosis.

H B Pollard, C J Pazoles, C E Creutz, O Zinder.   

Abstract

A central problem in cellular neurobiology is how the process of exocytosis of transmitters and hormones is regulated at the molecular level. Calcium is important in the process and may act by initiating the formation of fusion complexes of secretory granules to each other and to plasma membranes. We have discovered and isolated a new 47,000 MW protein (synexin) from adrenal medulla tissue that fuses chromaffin granule membranes only in the presence of calcium. Synexin activity was detected in a number of secretory tissues including human platelets and bovine brain, and the synexin molecule was found by immunofluorescent cytochemistry to be localized to the cytoplasm of chromaffin cells. Purified synexin molecules were found to self-associate in the presence of Ca++ to form paracrystalline arrays of 50 X 150 A rods, and the association was dependent on [Ca++] in an identical fashion to the Ca++ dependence of granule membrane fusion. On the basis of these data we suggest that synexin may be the intracellular receptor for calcium during exocytosis. However, the actual release event of 'fission' of the secretory vesicle-plasma membrane complex did not appear to be related to synexin action, and we have considered the hypothesis that the chemiosmotic mechanism for ATP, Cl--dependent chromaffin granule lysis might provide the necessary localized force. We have now shown that the granule model successfully predicts the secretory properties of human platelets, bovine parathyroid cells, and bovine chromaffin cells. Like the granule lysis system, secretion from these cells required specific anions in the medium was inhibited by anion transport blocking drugs and proton ionophores, and was suppressed by elevated osmotic strength. We suggest that secretory granules fused to plasma membranes in secreting cells, perhaps by synexin, may experience net solute uptake and subsequently undergo local, outwardly directed osmotic lysis, or exocytosis.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6112701     DOI: 10.1159/000388818

Source DB:  PubMed          Journal:  Monogr Neural Sci        ISSN: 0300-5186


  7 in total

1.  The late stage of human immunodeficiency virus type 1 assembly is an energy-dependent process.

Authors:  M Tritel; M D Resh
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

2.  Purification, crystallization and X-ray diffraction analysis of human synaptotagmin 1 C2A-C2B.

Authors:  Miguel Montes; Kerry L Fuson; R Bryan Sutton; J Justin Robert
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2006-08-26

3.  Cloning, expression, purification, crystallization and preliminary X-ray diffraction crystallographic study of human synaptotagmin 5 C2A domain.

Authors:  Xiaoting Qiu; Kai Huang; Yiwei Liu; Xiao Zhang; Yongxiang Gao
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2011-10-27

4.  Anion blockers inhibit impulse-evoked quantal transmitter release at the crayfish neuromuscular junction.

Authors:  W D Niles; D O Smith
Journal:  J Physiol       Date:  1982-08       Impact factor: 5.182

5.  Water secretion associated with exocytosis in endocrine cells revealed by micro forcemetry and evanescent wave microscopy.

Authors:  Takashi Tsuboi; Toshiteru Kikuta; Takashi Sakurai; Susumu Terakawa
Journal:  Biophys J       Date:  2002-07       Impact factor: 4.033

6.  Crystal structure of the cytosolic C2A-C2B domains of synaptotagmin III. Implications for Ca(+2)-independent snare complex interaction.

Authors:  R B Sutton; J A Ernst; A T Brunger
Journal:  J Cell Biol       Date:  1999-11-01       Impact factor: 10.539

7.  Annexin-phospholipid interactions. Functional implications.

Authors:  María Antonia Lizarbe; Juan I Barrasa; Nieves Olmo; Francisco Gavilanes; Javier Turnay
Journal:  Int J Mol Sci       Date:  2013-01-28       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.